These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8959631

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of intermittent intraperitoneal ceftazidime.
    Grabe DW, Bailie GR, Eisele G, Frye RF.
    Am J Kidney Dis; 1999 Jan; 33(1):111-7. PubMed ID: 9915275
    [Abstract] [Full Text] [Related]

  • 4. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
    Peerapornratana S, Chariyavilaskul P, Kanjanabuch T, Praditpornsilpa K, Eiam-Ong S, Katavetin P.
    Perit Dial Int; 2017 Jan; 37(2):218-224. PubMed ID: 27738089
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
    Sisterhen LL, Stowe CD, Farrar HC, Blaszak CK, Blaszak RT.
    Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections.
    Buijk SL, Gyssens IC, Mouton JW, Van Vliet A, Verbrugh HA, Bruining HA.
    J Antimicrob Chemother; 2002 Jan; 49(1):121-8. PubMed ID: 11751775
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
    Veys N, Lameire N, Malerczyk V, Lehr KH, Rosenkranz B, Ringoir S.
    Clin Pharmacol Ther; 1993 Oct; 54(4):395-401. PubMed ID: 8222482
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients.
    Elwell RJ, Manley HJ, Frye RF, Bailie GR.
    Int J Artif Organs; 2005 Aug; 28(8):808-16. PubMed ID: 16211531
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of intraperitoneal cefepime in automated peritoneal dialysis.
    Elwell RJ, Frye RF, Bailie GR.
    Perit Dial Int; 2005 Aug; 25(4):380-6. PubMed ID: 16022096
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis.
    Tourkantonis A, Nicolaidis P.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():263-7. PubMed ID: 6352629
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Manley HJ, Bailie GR, Asher RD, Eisele G, Frye RF.
    Perit Dial Int; 1999 Jul; 19(1):65-70. PubMed ID: 10201343
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics.
    Elwell RJ, Bailie GR, Manley HJ.
    Perit Dial Int; 2000 Jul; 20(6):694-8. PubMed ID: 11216561
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.